CClinicalTrials.gg
RecruitingNCT06116773Updated Dec 11, 2023

Effectiveness of Early Cardiac Rehabilitation

An interventional study of Training and Control in Coronary Artery Disease, sponsored by Istanbul University - Cerrahpasa. Recruiting at 1 site in Turkey. Open to participants aged 65 Years to 95 Years. Per ClinicalTrials.gov, last updated 2023-12-11.

Sponsored by Istanbul University - Cerrahpasa · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 3 months ago, but the record still lists the study as recruiting.
  • Started Dec 2023; still recruiting 2 years 10 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
65 Years to 95 Years
Sex
All
01

Study summary

The goal of this experimental study is to compare the effects of early (2nd week) cardiac rehabilitation applied in addition to usual care on functional capacity, quality of life, frailty and body composition in patients undergoing coronary artery bypass graft surgery.

The main questions it aims to answer are:

  • Does early cardiac rehabilitation contribute to increasing functional capacity?
  • Does early cardiac rehabilitation have positive effects on quality of life, frailty and body composition?

Participants will be divided into 2 groups (n = 50) in a randomized controlled manner. Patients in the training group (n:25) will participate in an 8-week supervised cardiac rehabilitation program as an outpatient after discharge. Patients in the control group (n:25) will be provided with usual care after discharge.

The control group will be informed about secondary prevention approaches and a home-based exercise program will be recommended. In addition to secondary prevention approaches and home-based exercise program, the training group will receive 3 sessions/week, 60 minutes of supervised cardiac rehabilitation for 8 weeks. All patients will be evaluated at baseline and after 8 weeks.

Researchers will compare training and control groups to see if effects on functional capacity, quality of life, frailty, body composition

Read the detailed description

Cardiovascular diseases are still the number one cause of death worldwide, despite significant advances in diagnosis and treatment over the last 50 years. Coronary artery bypass graft (CABG) surgery is an important treatment option for coronary heart disease. Cardiac rehabilitation (CR) programs are a planned multidisciplinary approach to supervise exercise and educate patients about coronary artery disease risk factors and disease management. Cardiac rehabilitation consists of 3 main phases: in-hospital period (phase 1); early post-discharge period (phase 2) and exercise training period (phase 3). Cardiac rehabilitation phase II (KRII) is a secondary prevention program designed to restore health following a cardiac event and reduce the risk of mortality and future cardiac events. It covers approximately 2-12 weeks after discharge. This is the period when patients are closely monitored. A gradual physical activity program is applied according to the results of the applied tests. Participation in KRII is known to reduce hospital readmissions and mortality. Referral to KRII following an acute cardiac event is a Class IA recommendation.

Outpatient CR programs are designed to reduce the deconditioning negative effects of medical and surgical interventions in cardiac patients and have well-accepted health and survival benefits. CR improves exercise capacity, quality of life, and long-term prognosis in patients with coronary artery disease. The beneficial effects of cardiac rehabilitation applied to patients after CABG surgery on exercise capacity, coronary risk factors and quality of life have been documented (PubMed identification (ID): 22064600). Positive benefits of postdischarge exercise training have been demonstrated (PubMed ID: 10961975), and it seems reasonable to begin exercise training immediately after CABG surgery (PubMed ID: 23851406). A recent multicenter study showed that patients who actively participated in an outpatient CR program after CABG surgery exhibited greater improvement in exercise capacity and better survival without cardiovascular events than those who did not participate in the CR program (PubMed ID: 32037378).

Prior to this, international guidelines did not recommend resistance training as part of the CR program immediately after CABG surgery, with the rationale that physical exertion causes pressure or stress in the sternal area and should therefore be avoided for at least 6 weeks and 3 months after surgery. However, results of a published meta-analysis (PubMed ID: 20482475) suggest that resistance training is an effective exercise program to improve 6-minute walking distance in individuals with chronic heart failure.

The goals of resistance training in older adults are to increase exercise and functional capacity, reduce activity limitation, and improve functionality in performing daily activity, thereby improving social reintegration and health-related quality of life. Resistance training in older adults may increase muscle strength and endurance and thus prevent age-related loss of skeletal muscle mass and strength as well as loss of bone mass. Strength and balance are closely related and are important in improving dynamic balance and increasing strength, which helps maintain activities of daily living and prevent frailty in very old adults. Studies have been conducted to evaluate the effects of combined aerobic and resistance training on the functional capacity of patients undergoing CABG surgery. Studies (PubMed ID: 19477380, PubMed ID: 19782265) showed that combined training caused a significant improvement in peak oxygen uptake in this patient population. While CR is recommended to begin as soon as possible after discharge, enrollment typically occurs several weeks after hospital discharge. This creates a gap in rehabilitative care. Reduced physiological reserve resulting from surgery, hospitalization, and the recovery period between discharge and CR may increase the risk of postoperative complications, readmission, and physical disability. It is known that a delay in starting CR prolongs recovery, increases dependency on family/caregivers, and especially those of working age are negatively affected. Additionally, any delay may reduce the benefits of KR.

Many patients rapidly lose muscle and bone mass during sedentary periods after sternotomy, increasing the risk of falls and prolonging recovery time. Accordingly, a number of preliminary studies have shown superior results when activity is started earlier after sternotomy. (PubMed ID: 26722187, PubMed ID: 28101566, PubMed ID: 29602750, PubMed ID: 31504913). A current study also proved that starting exercise training 2 weeks after sternotomy is effective and safe (PubMed ID: 35731506 ).With this study plan, we hypothesized that comprehensive cardiac rehabilitation in the early period after CABG would increase functional capacity. The aim of our study is to investigate the effectiveness of early (2nd week) phase 2 cardiac rehabilitation compared to usual care in patients undergoing CABG surgery, based on the primary outcome of functional capacity and secondary outcomes of quality of life, frailty, and body composition. This study will be an important study investigating the effects of phase 2 cardiac rehabilitation applied in the early period (2nd week) after CABG surgery on functional capacity, quality of life, fragility and body composition.

02

Conditions studied

  • Coronary Artery Disease

Keywords

  • Early Cardiac Rehabilitation
  • Coronary Artery Bypass Graft Surgery
  • Functional Capacity
  • Quality of Life
  • Frailty
03

In context

Coronary Artery Disease

5,598 studies on the registry are indexed under Coronary Artery Disease; 957 are open to participants now.

This study's planned enrollment of 50 is below the median of 124 across 3,436 interventional studies indexed under Coronary Artery Disease.

Browse Coronary Artery Disease studies →

Lead sponsor

Istanbul University - Cerrahpasa is the lead sponsor of 680 studies on the registry; 208 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 95 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • ⩾65 years old patients who underwent CABG surgery in the 2nd week post-op
  • No contraindications for exercise training and ability to exercise
  • Patients without diagnosed cognitive impairment

Exclusion criteria

Exclusion Criteria:

  • Cardiac arrhythmias that pose a serious risk
  • Unstable angina
  • Decompensated heart failure
  • Unstable blood pressure control
  • Peripheral artery disease with claudication
  • Severe myocardial ischemia
  • Cerebrovascular disease
  • Orthopedic disease
  • Chronic kidney disease (creatinine >3.0 mg/dL)
  • Liver dysfunction (alanine aminotransferase >200 U/L)
  • Other serious organ failure and/or other medical causes (e.g. difficulty walking)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Training Group

    Training group, in addition to secondary prevention approaches and home exercise program, will be applied 3 sessions/week, 60 minutes of supervised cardiac rehabilitation program for 8 weeks.

    Other: Training

  • Active comparator
    Control Group

    Control group will be informed about secondary prevention approaches and a home exercise program will be recommended.

    Other: Control

Interventions

  • OtherTraining

    Training group is supervised exercise group and will be included in a supervised cardiac rehabilitation program for 3 days a week. The program will start 2 weeks after CABG surgery and continue for 8 weeks, totaling 24 sessions. Aerobic, resistance, balance and stretching exercises will be applied within the program. Total exercise time is aimed to be ≥150 min/week for 8 weeks. A home-based exercise program will be recommended. Moderate-intensity continuous aerobic training will be implemented using an upright exercise bike (5 minutes warm-up, 20 minutes load, 5 minutes cool down, 5 minutes recovery). Rhythmic unloaded aerobic exercises or low-load (0.5-1 kg) resistance exercises (starting from the 6th week post-op) will be performed for an average of 15-20 minutes. Balance exercises will progress from easy to difficult depending on the person's performance. Stretching exercise for the gastrocnemius muscle will be performed for 4 repetitions in a short stretching period of 15 seconds.

  • OtherControl

    Patients will be informed about secondary prevention approaches which is routinely performed after discharge after CABG operation and will be recommended a home-based exercise program. Patients will be called by phone once a week and exercise monitoring will be provided. Recommended home exercise program includes: * Breathing exercises * Moderate intensity (RPE 4-6) walking (150 min/week). * Posture exercises (shoulder elevation-depression, 90 degree shoulder flex-extend, 90 degree shoulder abd-add, neck joint range of motion exercises) * They will be advised to continue range of motion exercises in the early post-operative period. (Twice a day, 10 repetitions).These exercises include ankle dorsi-plantar flexion, hip abduction-adduction, hip internal-external rotation, hip flexion-extension, arm elevation-depression in the supine position; flexion-extension in the sitting position; hip abduction-adduction, hip hyperextension and counting movements in the standing position.

06

What researchers measure

Primary outcomes

  1. Six minute walk test (6MWT)

    Functional capacity will be evaluated with the 6-minute walk test (6MWT). Patients will be walked in a 30-meter-long corridor for 6 minutes and the maximum walking distance will be measured. Before and after the test, heart rate, blood pressure and O2 saturation will be measured with pulse oximetry, and dyspnea and fatigue levels will be determined according to the Modified Borg scale.

    Time frame: eight weeks

Secondary outcomes

  1. Modified Borg Scale

    Modified Borg Scale is used to determine the level of dyspnea and fatigue at rest and with exertion. Dyspnea and fatigue levels before and after 6 WT will be evaluated with the 'Modified Borg Dyspnea' and 'Modified Borg Fatigue' scales. These scales are subjective scales. In addition to being frequently used to determine the severity of dyspnea and fatigue observed with exertion, they are also suitable for the evaluation of dyspnea and fatigue at rest. They consist of ten items that indicate the severity of dyspnea and fatigue according to their degree. Scoring is made between 0: none at all - 10: very severe.

    Time frame: eight weeks

  2. New York Heart Association (NYHA) functional classification

    Patients are classified from I to IV according to their physical activities. It is a strong prognosis indicator and risk marker. As the functional class increases, the survival rate decreases.

    Time frame: eight weeks

  3. Modified Medical Research Council (MMRC) dyspnea scale

    It is used to assess dyspnea. MMRC is a scale developed to evaluate the dyspnea degree of patients more objectively. 5 points include activities that provoke a feeling of breathlessness, such as walking and climbing stairs. In less than a minute, the patient chooses a score from the MMRC scale based on his/her degree of dyspnea. The MMRC scale is defined as a differential tool that categorizes patients according to their disease levels.

    Time frame: eight weeks

  4. Frail Scale

    It is used to assess frailty. It consists of 5 items; fatigue state, resistance, mobility, weight loss, and existing diseases. Depending on the answer given by the patients, a score of zero or one is given. Patients with a total score of zero are considered non-frail, 1-2 points are considered pre-frail, and patients with \>2 points are considered frail.

    Time frame: eight weeks

  5. Short Physical Performance Battery

    It consists of 3 objective tests that evaluate balance, walking speed and chair rising performance. Each test is scored between 0 (inability to complete the test) and 4 (highest level of performance). The scores from all three tests are summed to obtain a total score of 0-12. For a diagnosis of frailty, a total score of ≤5/12 is expected. 4 Meter Walking Test: The person is asked to walk at normal walking speed for 4 meters. Five Times Sit to Stand Test: The person is asked to sit on the chair and stand up 5 times as quickly as possible and without stopping, crossing his arms on his chest, and the time elapsed when the fifth repetition is completed is recorded. Balance Tests: For static balance assessment, the person is asked to maintain 3 different standing postures (feet side by side, semi-tandem and tandem positions), which gradually become more difficult, for 10 seconds.

    Time frame: eight weeks

  6. Mac New Heart Disease Health-Related Quality of Life Questionnaire

    It is a scale developed to determine the quality of life in heart diseases, consisting of 27 items, each with a 7-point Likert-type response. Three sub-groups (emotional, physical and social) and total score values are used in the evaluation of the scale. When calculating the scores for the sub-groups and the overall scale, the averages of the items in each dimension are taken. Therefore, scores range from 1 to 7 on average. A low score indicates worse quality of life, a high score indicates better quality of life.

    Time frame: eight weeks

  7. Muscle strength

    The hand grip strength measurement test is to test the maximum isometric contraction strength of the hand and forearm muscles. A hand grip dynamometer is used to perform the test. Grip strength should be assessed while the patient is sitting in a chair. Elbows are kept close to the body and 90° flexed. The wrist is in neutral. The person to be measured is asked to grasp the dynamometer and squeeze it as hard as he can. The test result is determined by calculating the average of three measurements.

    Time frame: eight weeks

  8. Body composition

    It will be determined using a multifrequency bioelectric body impedance analysis (BIA) device. All measurements are taken in the morning and with as little clothing as possible. Participants are informed to urinate before measurement, not to engage in heavy physical activity within 12 hours, not to drink alcohol in the last 24 hours, and not to consume anything solid or liquid in the last 3 hours. After the participants' height and age information are entered into the software, they are asked to step on the aluminum insoles on the bottom of the device and hold the handles. As a result of the evaluation, the body Weight (kg), body mass index (BMI, kg/m2), fat percentage, muscle weight (kg), fluid percentage and amount of internal fat (kg) are recorded.

    Time frame: eight weeks

07

Study locations

1 of 1 sites recruiting
  • Basaksehir Cam and Sakura City Hospital
    Istanbul, 34480, Turkey
    Recruiting
08

References and documents

Publications

  • Hillis LD, Smith PK, Anderson JL, Bittl JA, Bridges CR, Byrne JG, Cigarroa JE, Disesa VJ, Hiratzka LF, Hutter AM Jr, Jessen ME, Keeley EC, Lahey SJ, Lange RA, London MJ, Mack MJ, Patel MR, Puskas JD, Sabik JF, Selnes O, Shahian DM, Trost JC, Winniford MD. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011 Dec 6;124(23):2610-42. doi: 10.1161/CIR.0b013e31823b5fee. Epub 2011 Nov 7. No abstract available. Erratum In: Circulation. 2011 Dec 20;124(25):e956. Circulation. 2012 Aug 14;126(7):e105. PubMed 22064600 ↗
  • Balady GJ, Ades PA, Comoss P, Limacher M, Pina IL, Southard D, Williams MA, Bazzarre T. Core components of cardiac rehabilitation/secondary prevention programs: A statement for healthcare professionals from the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation Writing Group. Circulation. 2000 Aug 29;102(9):1069-73. doi: 10.1161/01.cir.102.9.1069. No abstract available. PubMed 10961975 ↗
  • Thompson PD, Arena R, Riebe D, Pescatello LS; American College of Sports Medicine. ACSM's new preparticipation health screening recommendations from ACSM's guidelines for exercise testing and prescription, ninth edition. Curr Sports Med Rep. 2013 Jul-Aug;12(4):215-7. doi: 10.1249/JSR.0b013e31829a68cf. No abstract available. PubMed 23851406 ↗
  • Origuchi H, Itoh H, Momomura SI, Nohara R, Daida H, Masuda T, Kohzuki M, Makita S, Ueshima K, Nagayama M, Omiya K, Adachi H, Goto Y. Active Participation in Outpatient Cardiac Rehabilitation Is Associated With Better Prognosis After Coronary Artery Bypass Graft Surgery - J-REHAB CABG Study. Circ J. 2020 Feb 25;84(3):427-435. doi: 10.1253/circj.CJ-19-0650. Epub 2020 Feb 8. PubMed 32037378 ↗
  • Hwang CL, Chien CL, Wu YT. Resistance training increases 6-minute walk distance in people with chronic heart failure: a systematic review. J Physiother. 2010;56(2):87-96. doi: 10.1016/s1836-9553(10)70038-2. PubMed 20482475 ↗
  • Onishi T, Shimada K, Sunayama S, Ohmura H, Sumide T, Masaki Y, Fukao K, Nishitani M, Kume A, Sato H, Naito H, Kawai S, Amano A, Daida H. Effects of cardiac rehabilitation in patients with metabolic syndrome after coronary artery bypass grafting. J Cardiol. 2009 Jun;53(3):381-7. doi: 10.1016/j.jjcc.2009.01.004. Epub 2009 Feb 23. PubMed 19477380 ↗
  • Sumide T, Shimada K, Ohmura H, Onishi T, Kawakami K, Masaki Y, Fukao K, Nishitani M, Kume A, Sato H, Sunayama S, Kawai S, Shimada A, Yamamoto T, Kikuchi K, Amano A, Daida H. Relationship between exercise tolerance and muscle strength following cardiac rehabilitation: comparison of patients after cardiac surgery and patients with myocardial infarction. J Cardiol. 2009 Oct;54(2):273-81. doi: 10.1016/j.jjcc.2009.05.016. PubMed 19782265 ↗
  • Adams J, Lotshaw A, Exum E, Campbell M, Spranger CB, Beveridge J, Baker S, McCray S, Bilbrey T, Shock T, Lawrence A, Hamman BL, Schussler JM. An alternative approach to prescribing sternal precautions after median sternotomy, "Keep Your Move in the Tube". Proc (Bayl Univ Med Cent). 2016 Jan;29(1):97-100. doi: 10.1080/08998280.2016.11929379. PubMed 26722187 ↗
  • El-Ansary D, LaPier TK, Adams J, Gach R, Triano S, Katijjahbe MA, Hirschhorn AD, Mungovan SF, Lotshaw A, Cahalin LP. An Evidence-Based Perspective on Movement and Activity Following Median Sternotomy. Phys Ther. 2019 Dec 16;99(12):1587-1601. doi: 10.1093/ptj/pzz126. PubMed 31504913 ↗
  • Katijjahbe MA, Granger CL, Denehy L, Royse A, Royse C, Bates R, Logie S, Nur Ayub MA, Clarke S, El-Ansary D. Standard restrictive sternal precautions and modified sternal precautions had similar effects in people after cardiac surgery via median sternotomy ('SMART' Trial): a randomised trial. J Physiother. 2018 Apr;64(2):97-106. doi: 10.1016/j.jphys.2018.02.013. Epub 2018 Mar 27. PubMed 29602750 ↗
  • Mungovan SF, Singh P, Gass GC, Smart NA, Hirschhorn AD. Effect of physical activity in the first five days after cardiac surgery. J Rehabil Med. 2017 Jan 19;49(1):71-77. doi: 10.2340/16501977-2165. PubMed 28101566 ↗
  • Ennis S, Lobley G, Worrall S, Evans B, Kimani PK, Khan A, Powell R, Banerjee P, Barker T, McGregor G. Effectiveness and Safety of Early Initiation of Poststernotomy Cardiac Rehabilitation Exercise Training: The SCAR Randomized Clinical Trial. JAMA Cardiol. 2022 Aug 1;7(8):817-824. doi: 10.1001/jamacardio.2022.1651. PubMed 35731506 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 11, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06116773
Lead sponsor
Istanbul University - Cerrahpasa
Responsible party
Raziye Ceylan (master of science, Istanbul University - Cerrahpasa) — Principal investigator
First posted
Nov 3, 2023
Start date
Dec 1, 2023
Primary completion
Jul 1, 2025 (estimated)
Completion
Dec 1, 2025 (estimated)
Last update
Dec 11, 2023

Study contacts

Raziye Ceylan
Contact
raziyeceylan87@gmail.com
+905068825393
Rengin Demir, Prof
study director · Istanbul University - Cerrahpasa
Raziye Ceylan, MSc
principal investigator · Istanbul University - Cerrahpasa

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion